[go: up one dir, main page]

MX2015007166A - Gel oral para sensibilidad y dolor dental. - Google Patents

Gel oral para sensibilidad y dolor dental.

Info

Publication number
MX2015007166A
MX2015007166A MX2015007166A MX2015007166A MX2015007166A MX 2015007166 A MX2015007166 A MX 2015007166A MX 2015007166 A MX2015007166 A MX 2015007166A MX 2015007166 A MX2015007166 A MX 2015007166A MX 2015007166 A MX2015007166 A MX 2015007166A
Authority
MX
Mexico
Prior art keywords
analgesic
sensitivity
oral gel
gel
tooth pain
Prior art date
Application number
MX2015007166A
Other languages
English (en)
Other versions
MX366533B (es
Inventor
Shashank Potnis
Ravi Subramanyam
Rajitha Nair
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of MX2015007166A publication Critical patent/MX2015007166A/es
Publication of MX366533B publication Critical patent/MX366533B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Se divulga en el presente documento geles analgésicos oralmente aceptables tópicos que comprende una mezcla de aceites analgésicos que comprende (a) aceite de clavo y/o eugenol, (b) un agente refrescante, y (c) alcanfor; en una base de gel oralmente aceptable, la base de gel que comprende un polímero aniónico y un aminoácido básico, y el gel analgésico proporcionando una liberación controlada de la mezcla de aceites analgésicos después de la aplicación a un diente; junto con los métodos de fabricación y uso del mismo.
MX2015007166A 2012-12-06 2013-03-07 Gel oral para sensibilidad y dolor dental. MX366533B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3759DE2012 2012-12-06
PCT/IN2013/000135 WO2014087419A1 (en) 2012-12-06 2013-03-07 Oral gel for sensitivity and tooth pain

Publications (2)

Publication Number Publication Date
MX2015007166A true MX2015007166A (es) 2015-10-12
MX366533B MX366533B (es) 2019-07-12

Family

ID=49213007

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015007166A MX366533B (es) 2012-12-06 2013-03-07 Gel oral para sensibilidad y dolor dental.

Country Status (9)

Country Link
US (1) US11033594B2 (es)
EP (1) EP2928450B1 (es)
CN (1) CN104812373B (es)
AU (1) AU2013353580B2 (es)
BR (1) BR112015012920A2 (es)
HK (1) HK1215162A1 (es)
MX (1) MX366533B (es)
WO (1) WO2014087419A1 (es)
ZA (1) ZA201503694B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2928451B1 (en) 2012-12-06 2017-07-26 Colgate-Palmolive Company Oral gel for relief of tooth pain
EP3367993B1 (en) * 2015-11-20 2025-11-19 Colgate-Palmolive Company Oral care composition comprising chitosan and silica
CN109310595A (zh) * 2016-05-14 2019-02-05 西姆莱斯股份公司 含有薄荷醇的香料制剂
US10426576B2 (en) 2017-10-12 2019-10-01 King Abdulaziz University Method for debonding of orthodontic metal brackets with eugenol emulgel
WO2020223097A1 (en) 2019-04-30 2020-11-05 Bayer Healthcare Llc Topical analgesic compositions
CA3138194A1 (en) 2019-04-30 2020-11-05 Bayer Healthcare Llc Topical analgesic gel compositions
US20230233641A1 (en) * 2022-01-07 2023-07-27 Colgate-Palmolive Company Oral gel compositions
CN117883307A (zh) 2022-10-13 2024-04-16 苏州欧丽特生物医药有限公司 凝胶组合物及其制备和应用
CN117530896B (zh) * 2024-01-10 2024-04-26 拉芳家化股份有限公司 一种含有稀有人参皂苷的口腔护理组合物及其应用

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3943241A (en) 1971-08-30 1976-03-09 General Mills, Inc. Cariostatic composition
US3932608A (en) 1971-08-30 1976-01-13 General Mills, Inc. Food composition
US3932605A (en) 1972-06-12 1976-01-13 Jaroslav Vit Dental treatment
US3988434A (en) 1972-08-07 1976-10-26 Schole Murray L Dental preparation
US4025616A (en) 1973-03-06 1977-05-24 The Procter & Gamble Company Oral compositions for plaque, caries and calculus retardation with reduced staining tendencies
US4100269A (en) 1973-06-28 1978-07-11 Lever Brothers Company Anticalculus dentifrice
US4022880A (en) 1973-09-26 1977-05-10 Lever Brothers Company Anticalculus composition
US3925543A (en) 1973-11-01 1975-12-09 Colgate Palmolive Co Antibacterial oral compositions containing preservative-antioxidants
US4011309A (en) 1975-01-20 1977-03-08 Marion Laboratories, Inc. Dentifrice composition and method for desensitizing sensitive teeth
US4064138A (en) 1975-11-12 1977-12-20 General Mills, Inc. Amino acid derivatives
USRE31181E (en) 1976-06-18 1983-03-15 Means and method for improving natural defenses against caries
ZA773318B (en) 1976-06-18 1978-04-26 I Kleinberg Means and method for improving natural defenses against caries
US4042680A (en) 1976-08-02 1977-08-16 Indiana University Foundation Anticariogenic maloaluminate complexes
US4108981A (en) 1976-08-02 1978-08-22 Indiana University Foundation Alkaline oral compositions comprising aluminum and a carboxylic acid
US4108979A (en) 1976-08-02 1978-08-22 Indiana University Foundation Dentifrice preparations comprising aluminum and a compatible abrasive
US4146607A (en) 1977-11-07 1979-03-27 Lever Brothers Company Synergistic anti-plaque mixture with tetradecylamine plus aluminum and/or zinc
US4160821A (en) 1978-02-27 1979-07-10 Johnson & Johnson Treatment for gingivitis
US4213961A (en) 1978-03-23 1980-07-22 Beecham, Inc. Oral compositions
GB1573727A (en) 1978-05-19 1980-08-28 Colgate Palmolive Co Dentifrices
US4225579A (en) 1979-02-27 1980-09-30 Israel Kleinberg Means and method for improving defenses against caries
US4339432A (en) 1979-06-20 1982-07-13 Lever Brothers Company Oral mouthwash containing zinc and glycine
US4269822A (en) 1979-07-20 1981-05-26 Laclede Professional Products, Inc. Antiseptic dentifrice
JPS5846483B2 (ja) 1979-09-20 1983-10-17 ライオン株式会社 口腔用組成物
JPS5835965B2 (ja) 1979-07-31 1983-08-05 ライオン株式会社 口腔用組成物
US4532124A (en) 1981-08-19 1985-07-30 Development Finance Corporation Of New Zealand Dental rinse
JPS58118509A (ja) 1981-12-29 1983-07-14 Lion Corp 口腔用組成物
US4725576A (en) 1983-12-29 1988-02-16 Research Foundation Of State University Of New York Fungicidal polypeptide compositions containing L-histidine and methods for use therefore
US4528181A (en) 1984-02-01 1985-07-09 Colgate-Palmolive Company Dentifrice containing dual sources of fluoride
US5334617A (en) 1984-03-19 1994-08-02 The Rockefeller University Amino acids useful as inhibitors of the advanced glycosylation of proteins
GB8411731D0 (en) 1984-05-09 1984-06-13 Unilever Plc Oral compositions
JPH0742219B2 (ja) 1984-07-26 1995-05-10 ライオン株式会社 口腔用組成物
US4538990A (en) 1984-09-24 1985-09-03 Medical College Of Ga. Research Institute, Inc. Method of decreasing the permeability of a dental cavity
GB8729564D0 (en) 1987-12-18 1988-02-03 Unilever Plc Oral compositions
US5438076A (en) 1988-05-03 1995-08-01 Perio Products, Ltd. Liquid polymer composition, and method of use
US5096700A (en) 1990-09-28 1992-03-17 The Procter & Gamble Company Halogenated aminohexanoates and aminobutyrates antimicrobial agents
US5370865A (en) 1992-05-15 1994-12-06 Kao Corporation Composition for use in oral cavity
US5286480A (en) 1992-06-29 1994-02-15 The Procter & Gamble Company Use of N-acetylated amino acid complexes in oral care compositions
EP0839021B1 (en) 1995-07-10 2002-01-23 Unilever N.V. Self-heating dentifrice
US5762911A (en) 1996-03-05 1998-06-09 The Research Foundation Of State University Of New York Anti-caries oral compositions
US6488961B1 (en) 1996-09-20 2002-12-03 Ethypharm, Inc. Effervescent granules and methods for their preparation
US5906811A (en) 1997-06-27 1999-05-25 Thione International, Inc. Intra-oral antioxidant preparations
US5922332A (en) 1997-09-17 1999-07-13 Fossel; Eric T. Topical delivery of arginine to overcome pain
US5922346A (en) 1997-12-01 1999-07-13 Thione International, Inc. Antioxidant preparation
US6805883B2 (en) 1998-03-12 2004-10-19 Mars, Incorporated Food products containing polyphenol(s) and L-arginine to stimulate nitric oxide
US6319513B1 (en) * 1998-08-24 2001-11-20 The Procter & Gamble Company Oral liquid mucoadhesive compounds
US5997301A (en) 1998-10-20 1999-12-07 Linden; Lars Ake Treatment of tooth surfaces and substances therefor
US6436370B1 (en) 1999-06-23 2002-08-20 The Research Foundation Of State University Of New York Dental anti-hypersensitivity composition and method
US20050175959A1 (en) * 2000-03-14 2005-08-11 Coll Partners Ltd. System for the controlled delivery of an active material to a dental site
WO2001076549A2 (en) 2000-04-11 2001-10-18 Gerald Mc Laughlin Composition and method for whitening teeth
US20020081360A1 (en) 2000-12-27 2002-06-27 Andreas Burgard Salts of L-amino acid having improved taste and their preparation
US6531115B1 (en) 2001-01-03 2003-03-11 Council Of Scientific & Industrial Research Analgesic and refreshing herbal composition and a process for preparing the same
KR20030097892A (ko) * 2001-05-25 2003-12-31 에스에스 세야쿠 가부시키 가이샤 의약 배합제
US6669929B1 (en) * 2002-12-30 2003-12-30 Colgate Palmolive Company Dentifrice containing functional film flakes
US20060140882A1 (en) * 2004-12-29 2006-06-29 Tambs Gary E Two phase whitening oral care composition
US20060140885A1 (en) * 2004-12-29 2006-06-29 Abdul Gaffar Method of reducing oral tissue inflammation using magnolia extract
US20080267891A1 (en) 2007-04-30 2008-10-30 Colgate-Palmolive Company Oral Care Composition To Reduce Or Eliminate Dental Sensitivity
RU2505282C2 (ru) * 2008-02-08 2014-01-27 Колгейт-Палмолив Компани Композиции и устройства
EP2252169A4 (en) 2008-02-08 2013-08-21 Colgate Palmolive Co ARGINE-CONTAINING DRINK
WO2010068428A1 (en) * 2008-11-25 2010-06-17 The Procter & Gamble Company Oral care compositions with improved aesthetics and fused silica
EP2928451B1 (en) 2012-12-06 2017-07-26 Colgate-Palmolive Company Oral gel for relief of tooth pain

Also Published As

Publication number Publication date
EP2928450A1 (en) 2015-10-14
WO2014087419A1 (en) 2014-06-12
MX366533B (es) 2019-07-12
HK1215162A1 (zh) 2016-08-19
US20160143978A1 (en) 2016-05-26
US11033594B2 (en) 2021-06-15
EP2928450B1 (en) 2017-03-01
CN104812373A (zh) 2015-07-29
ZA201503694B (en) 2017-08-30
AU2013353580A1 (en) 2015-05-28
BR112015012920A2 (pt) 2017-07-11
CN104812373B (zh) 2019-01-08
AU2013353580B2 (en) 2015-08-20

Similar Documents

Publication Publication Date Title
MX2015007166A (es) Gel oral para sensibilidad y dolor dental.
PH12015501085A1 (en) Oral gel for relief of tooth pain
CR20140541A (es) Formulaciones farmacéuticas tópicas no acuosas
UY35210A (es) Inhibidores de autotaxina
CU20170172A7 (es) 4,6-diaminoquinolin-3-carbonitrilos sustituidos útiles como agentes analgésicos, antipiréticos o antiinflamatorios y antineoplásicos
CL2016002560A1 (es) Forma de dosificación farmacéutica sólida oral que comprende siponimod, un agente protector de la humedad y opcionalmente un excipiente farmacéutico; procedimiento de preparación.
DOP2015000100A (es) Inhibidores de la tirosina-quinasa de bruton
MX2015009104A (es) Composiciones en solución sólida y uso en el tratamiento de enfermedades cardiovasculares.
MX386820B (es) Microcápsulas lipídicas que comprenden de preferencia un retinoide y composición que las contiene, su procedimiento de preparación y su uso en dermatología.
NZ726746A (en) Stable cannabinoid formulations
DOP2015000108A (es) Compuestos de pirrolopirimidina como inhibidores de quinasas
MX2015009772A (es) Moduladores de receptores nmda de espiro-lactama y sus usos.
EA201690810A1 (ru) Мягкие пастилки, содержащие экстракт куркумы
CL2015003072A1 (es) Formulaciones de liberación prolongada de colchicina y métodos de uso de las mismas.
CR20150402A (es) Formulaciones farmacéuticas resistentes a la manipulación indebida
CL2015002433A1 (es) Imidazopiridazinas sustituidas
CL2015002692A1 (es) Novedosos compuestos de bencenosulfonamida, método para sintetizarlos y uso de los compuestos en medicina y en cosméticos.
CO6640216A2 (es) Composiciones farmacéuticas que comprenden hidromorfona y naloxona
EA201690005A1 (ru) Состав с модифицированной кинетикой высвобождения
MX2015010486A (es) Composicion masticable para administracion oral y proceso para preparar la misma.
UA119441C2 (uk) Посилювачі водорозчинності на основі глікогену
BR112015015084A2 (pt) composição para cuidado oral
MX2020006075A (es) Composiciones farmaceuticas de bendamustina.
CR20150411A (es) Composiciones farmacéuticas que contienen dexketoprofeno y tramadol
CL2011003355A1 (es) Compuestos derivados de alcoxi-carbonil-amino-alquinil-adenosina ; composición farmacéutica que los comprende; uso del compuesto en la preparación de un medicamento útil para tratar enfermedades autoinmunes, inflamatorias, alérgicas, infecciosas entre otras.

Legal Events

Date Code Title Description
FG Grant or registration